I don't need to be careful when I have facts on my
Post# of 30067
Posted On: 11/18/2014 11:19:12 PM
I don't need to be careful when I have facts on my side.
Eltoprazine was licensed by AMBS back on Jan 14th. PPS was at .089 on the 13th and spiked to .1189 on the 14th, day of the announcement. The stock then fluctuated heavily until the end of Jan when it started a downward decline. Why did that happen you ask? Well, many people though we were going to get good Lympro news at the end of Jan. That didn't happen. Yesterday's news gave the stock a temp spike which was all given up today. The market understands that ELto and ESS and MANF are years away. But Lympro. What the hell is going on with Lympro? The market is waiting and so far we don't know squat. If the hype that Gerald has built about Lympro doesn't materialize, those who have their 87% gains will see them dash back to 0% very quickly. All eyes are on lympro.
Eltoprazine was licensed by AMBS back on Jan 14th. PPS was at .089 on the 13th and spiked to .1189 on the 14th, day of the announcement. The stock then fluctuated heavily until the end of Jan when it started a downward decline. Why did that happen you ask? Well, many people though we were going to get good Lympro news at the end of Jan. That didn't happen. Yesterday's news gave the stock a temp spike which was all given up today. The market understands that ELto and ESS and MANF are years away. But Lympro. What the hell is going on with Lympro? The market is waiting and so far we don't know squat. If the hype that Gerald has built about Lympro doesn't materialize, those who have their 87% gains will see them dash back to 0% very quickly. All eyes are on lympro.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.